ASX - By Stock
|
SPL |
Re:
Looks like the fat lady has not yet sung on AZD4320
|
|
Wingmann
|
31 |
6.6K |
4 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
31
|
6.6K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Looks like the fat lady has not yet sung on AZD4320
|
|
Wingmann
|
31 |
6.6K |
7 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
31
|
6.6K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
Clinical trial thoughts
|
|
Wingmann
|
40 |
7.5K |
3 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
40
|
7.5K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Clinical trial thoughts
|
|
Wingmann
|
40 |
7.5K |
2 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
40
|
7.5K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Viraleze shows antiviral efficacy in COVID-19 patients
|
|
Wingmann
|
74 |
14K |
7 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
74
|
14K
|
7
|
|
ASX - By Stock
|
SPL |
Re:
Shareholders Meeting
|
|
Wingmann
|
9 |
1.4K |
1 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
9
|
1.4K
|
1
|
|
ASX - By Stock
|
CTP |
Re:
Sub salt Helium and Hydrogen
|
|
Wingmann
|
31 |
8.8K |
4 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
31
|
8.8K
|
4
|
|
ASX - By Stock
|
FIN |
Re:
Ann: Becoming a substantial holder
|
|
Wingmann
|
6 |
2.2K |
3 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
6
|
2.2K
|
3
|
|
ASX - By Stock
|
SPL |
Astrazeneca-showcases-scientific-advances
|
|
Wingmann
|
3 |
1.1K |
13 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
3
|
1.1K
|
13
|
|
ASX - By Stock
|
SPL |
Re:
Mckesson UK and AURELIUS
|
|
Wingmann
|
107 |
24K |
0 |
22/03/23 |
22/03/23 |
ASX - By Stock
|
107
|
24K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Everyone locked and loaded???
|
|
Wingmann
|
28 |
8.9K |
1 |
27/01/23 |
27/01/23 |
ASX - By Stock
|
28
|
8.9K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE Post-Market Clinical Study in COVID-19 Patients
|
|
Wingmann
|
54 |
13K |
5 |
26/01/23 |
26/01/23 |
ASX - By Stock
|
54
|
13K
|
5
|
|
ASX - By Stock
|
SPL Medicine |
Re:
Has Starpharma Viraleze suffered from BIOPHARMA Lobbying
|
|
Wingmann
|
31 |
43K |
5 |
19/01/23 |
19/01/23 |
ASX - By Stock
|
31
|
43K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
XBB15 VARIANT DOMINANT STRAIN
|
|
Wingmann
|
56 |
15K |
0 |
17/01/23 |
17/01/23 |
ASX - By Stock
|
56
|
15K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
XBB15 VARIANT DOMINANT STRAIN
|
|
Wingmann
|
56 |
15K |
3 |
14/01/23 |
14/01/23 |
ASX - By Stock
|
56
|
15K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
XBB15 VARIANT DOMINANT STRAIN
|
|
Wingmann
|
56 |
15K |
3 |
13/01/23 |
13/01/23 |
ASX - By Stock
|
56
|
15K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
XBB15 VARIANT DOMINANT STRAIN
|
|
Wingmann
|
56 |
15K |
3 |
11/01/23 |
11/01/23 |
ASX - By Stock
|
56
|
15K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
XBB15 VARIANT DOMINANT STRAIN
|
|
Wingmann
|
56 |
15K |
3 |
08/01/23 |
08/01/23 |
ASX - By Stock
|
56
|
15K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
XBB15 VARIANT DOMINANT STRAIN
|
|
Wingmann
|
56 |
15K |
4 |
06/01/23 |
06/01/23 |
ASX - By Stock
|
56
|
15K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
XBB15 VARIANT DOMINANT STRAIN
|
|
Wingmann
|
56 |
15K |
3 |
06/01/23 |
06/01/23 |
ASX - By Stock
|
56
|
15K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE launched in Hong Kong and Macau
|
|
Wingmann
|
111 |
26K |
4 |
24/11/22 |
24/11/22 |
ASX - By Stock
|
111
|
26K
|
4
|
|
ASX - By Stock
|
UCM |
Re:
Food for thought
|
|
Wingmann
|
95 |
18K |
3 |
21/09/22 |
21/09/22 |
ASX - By Stock
|
95
|
18K
|
3
|
|
ASX - By Stock
|
FIN |
Re:
Ann: Annual Report - 30 June 2022
|
|
Wingmann
|
4 |
2.6K |
2 |
20/09/22 |
20/09/22 |
ASX - By Stock
|
4
|
2.6K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: S&P DJI Announces September 2022 Quarterly Rebalance
|
|
Wingmann
|
35 |
11K |
2 |
13/09/22 |
13/09/22 |
ASX - By Stock
|
35
|
11K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
DEP Cabazitaxel Ph 2 Prostate cancer readout
|
|
Wingmann
|
20 |
6.2K |
3 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
20
|
6.2K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
AstraZeneca to buy Alexion for $39 billion
|
|
Wingmann
|
18 |
6.2K |
3 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
18
|
6.2K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Is this the start of a bull run
|
|
Wingmann
|
42 |
11K |
1 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
42
|
11K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Is this the start of a bull run
|
|
Wingmann
|
42 |
11K |
3 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
42
|
11K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Is this the start of a bull run
|
|
Wingmann
|
42 |
11K |
4 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
42
|
11K
|
4
|
|
ASX - By Stock
|
UCM |
Re:
Ann: Appendix 4E and Annual Report
|
|
Wingmann
|
17 |
3.4K |
2 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
17
|
3.4K
|
2
|
|
ASX - By Stock
|
UCM |
Re:
Ann: Appendix 4E and Annual Report
|
|
Wingmann
|
17 |
3.4K |
5 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
17
|
3.4K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Starpharma after 22 years
|
|
Wingmann
|
38 |
11K |
2 |
17/08/22 |
17/08/22 |
ASX - By Stock
|
38
|
11K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Starpharma after 22 years
|
|
Wingmann
|
38 |
11K |
2 |
16/08/22 |
16/08/22 |
ASX - By Stock
|
38
|
11K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Starpharma after 22 years
|
|
Wingmann
|
38 |
11K |
3 |
16/08/22 |
16/08/22 |
ASX - By Stock
|
38
|
11K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Starpharma after 22 years
|
|
Wingmann
|
38 |
11K |
3 |
16/08/22 |
16/08/22 |
ASX - By Stock
|
38
|
11K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
something has to give.....the share price is absolutely ridiculous
|
|
Wingmann
|
47 |
10K |
2 |
15/08/22 |
15/08/22 |
ASX - By Stock
|
47
|
10K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE relaunched by LloydsPharmacy in the UK
|
|
Wingmann
|
253 |
65K |
3 |
13/08/22 |
13/08/22 |
ASX - By Stock
|
253
|
65K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma signs new DEP agreement with MSD
|
|
Wingmann
|
39 |
12K |
0 |
12/08/22 |
12/08/22 |
ASX - By Stock
|
39
|
12K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
SPL chart
|
|
Wingmann
|
451 |
138K |
0 |
11/08/22 |
11/08/22 |
ASX - By Stock
|
451
|
138K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Is this the start of a bull run
|
|
Wingmann
|
42 |
11K |
0 |
11/08/22 |
11/08/22 |
ASX - By Stock
|
42
|
11K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma signs new DEP agreement with MSD
|
|
Wingmann
|
39 |
12K |
3 |
11/08/22 |
11/08/22 |
ASX - By Stock
|
39
|
12K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VIRALEZE relaunched by LloydsPharmacy in the UK
|
|
Wingmann
|
253 |
65K |
8 |
11/08/22 |
11/08/22 |
ASX - By Stock
|
253
|
65K
|
8
|
|
ASX - By Stock
|
SPL |
Re:
Is this the start of a bull run
|
|
Wingmann
|
42 |
11K |
6 |
11/08/22 |
11/08/22 |
ASX - By Stock
|
42
|
11K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma signs new DEP agreement with MSD
|
|
Wingmann
|
39 |
12K |
5 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
39
|
12K
|
5
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma signs new DEP agreement with MSD
|
|
Wingmann
|
39 |
12K |
1 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
39
|
12K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Starpharma signs new DEP agreement with MSD
|
|
Wingmann
|
39 |
12K |
4 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
39
|
12K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Viraleze
|
|
Wingmann
|
95 |
29K |
2 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
95
|
29K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Viraleze
|
|
Wingmann
|
95 |
29K |
3 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
95
|
29K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Viraleze
|
|
Wingmann
|
95 |
29K |
5 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
95
|
29K
|
5
|
|
ASX - By Stock
|
AFI |
Re:
Ann: NTA & Top 25 Investments as at 31 May 2022
|
|
Wingmann
|
28 |
13K |
0 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
28
|
13K
|
0
|
|